Intelligence · Clinical Development
Pipeline search results
Programs matching “alcohol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 117 pipeline programs matching "alcohol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo
BioXcel Therapeutics
Alcohol Use Disorder (AUD)
1 trial -
Spironolactone
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Use Disorder
1 trial -
TVB-2640 - 50 mg
Sagimet Biosciences
Non-alcoholic Steatohepatitis
1 trial -
intraconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
Alcohol Wipes vs. No Alcohol Wipes
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
Alcohol injection
The University of Hong Kong
Malignancy
1 trial -
Fluoxetine + outpatient cognitive behavioral therapy
BRIGHT MINDS BIOSCIENCES INC.
Alcohol-Related Disorders
1 trial -
OMACOR
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
Ornithine aspartate granule
The First People's Hospital of Lianyungang
Non-alcoholic Fatty Liver Disease
1 trial -
Pioglitazone
Takeda
Nonalcoholic Steatohepatitis
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Nonalcoholic Fatty Liver Disease
1 trial -
Topiramate
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
Alcohol(oral) and placebo
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Drinking
1 trial -
Empagliflozin
MEDA Pharma GmbH & Co. KG
Non Alcoholic Fatty Liver Disease
1 trial -
FSD-F2R6-A-CP
Quantum Biopharma
Acute Alcohol Intoxication
1 trial -
L-Carnitine tartrate
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Phytosterols & placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-alcoholic Fatty Liver Disease
1 trial -
Synbiotic
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
prazosin hydrochloride
United Therapeutics Europe Ltd
Alcohol Use Disorders
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.